Partnering with InnoCore means gaining a trusted, experienced ally in the formulation of your complex molecules in a sustained release, long-acting injectable (LAI) drug product.
We work in close collaboration with our customers to overcome the complex technical challenges of formulating and scaling their peptides and biologics with our best-in-class SynBiosys® polymeric drug delivery platform.
Our dynamic, multidisciplinary team offers agile, customized solutions for your molecules as they move from early to late stage clinical development.
Together, we can help you create sustained release drug products, add value to unlock longer product lifecycles and in the longer term, help you create a more effective and patient-compliant drug product; meaningful differentiation in a fast-growing, competitive market.
Using SynBiosys®, we extended peptide release to over 3 months with more than 90% activity retained. The release profile was also phenomenal.
Whether you are a Large Pharma, Biotech, Generic or Animal Health company, InnoCore’s bespoke offering will support you in developing unique long-acting dosage forms of your API
Different structures of license and development agreements are available, depending on your needs and preferences.
We create bespoke teams with a mixture of expertise depending on the project, that works for you, not only during the first feasibility phase, but also during all subsequent product development phases.
At InnoCore, our state-of-the-art facilities and experienced team support you every step of the way through the formulation of your drug product and manufacturing journey.
Once each project is complete, we can transfer to you or your cGMP contract manufacturing partner.
Feasibility studies for compatibility Polymer customization Encapsulation efficiency and API integrity
Offering customized solutions for your unique challenges
How do we support you through the early stages of feasibility?
Robust analytical validation Process scale-up & optimization GLP tox manufacturing
Developing reliable & robust process for manufacturing
How do we assist you through the process, scaling and GLP process?
cGMP batches
Scaling from grams to Kgs
Whether it’s just a few grams for a small research project of kilograms for clinical trials, we offer inhouse manufacturing of material for GLP-tox studies followed by technology transfer to our customer cGMP facilities or our partner network, if required.
Regulatory support and quality assurance form an integral part of our partner support services.
Dedicated production and quality control documentation is laid down with compliance to international high quality standards.
We can add tangible value to our partners’ drug programmes by translating their peptide or protein molecules into stable, scalable LAI drug products that maintain their essential characteristics.
The combination of our technology and our customers’ molecules can provide novel IP protection for our clients and creating higher entry market barriers for competition.
InnoCore is actively developing future versions of SynBiosys® to support:
Our aim is to extend SynBiosys®’s data package through InnoCore-formulated LAI reaching commercial status and in time, a SynBiosys® LAI reaching blockbuster status.
We believe in the power of partnerships – the added value of combined experience, know-how and skills – and to become an extension of our partners’ teams.
We are open to partnering and collaboration opportunities that complement our expertise and boosts the innovation process. If you are a developer and would like a discussion, please get in touch.
"*" indicates required fields